In a speech at the Annual Conference of the Club de Madrid, Angel Gurría focussed on the political economy of climate policies. He spoke about a range of policies that could be used to help address climate change, and the considerable challenges of implementing them.
This paper describes the compilation of these tables in the hope that this may benefit input-output compilers in national statistical offices and provide them with a better understanding of the information needed by the OECD to compile these tables in order to meet the demands of users.
English, , 1,610kb
The objective of the workshop was to identify and review the kinds of baseline information of (non-transgenic) traditional fish farming or breeding, and to determine what information might be relevant to risk/ safety assessment.
This paper is primarily aimed at a non-technical audience and focuses on the applications and important policy questions that can benefit from the availability of harmonised input-output tables, such as those developed over the years by the OECD.
This paper estimates domestic productivity relationships for a sample of 16 OECD countries through probably the most general specification yet.
The Blue Sky II Forum in Ottawa on 25-27 September 2006 will examine new areas for indicator development and set a broad agenda for future work on science, technology and innovation (STI) indicators.
This paper examines recent evidence and also reviews macroeconomic statistics related to the development of technology markets. It examines approaches to the valuation of patents and the policy initiatives undertaken by OECD countries to foster patent valuation and exploitation.
Publications on Harmonisation of Regulatory Oversight in Biotechnology
This paper examines the tax treatment of corporate expenditures on selected intellectual assets and develops an indicator of the relative generosity of tax systems in OECD countries to such investments.
English, , 849kb
The 2006 edition OECD Biotechnology Statistics includes data for 23 OECD countries and two observer countries, plus China (Shanghai), and takes a major step forward in improving the comparability of biotechnology indicators among countries.